Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak, M. Dror Michaelson, Ronald M. Bukowski, Olivier Rixe, Stéphane Oudard, Sylvie Négrier, Cezary Szczylik, Sindy T. Kim, Isan Chen, Paul Bycott, Charles M. Baum, Robert A. Figlin

New England Journal of Medicine, 2007

Memorial Sloan Kettering Cancer Center, Texas Oncology, Centrum Onkologii, Massachusetts General Hospital, Cleveland Clinic, Sorbonne Université, Pitié-Salpêtrière Hospital, Hôpital Européen, Hôpital Européen Georges-Pompidou, Centre Léon Bérard, Wojskowy Instytut Medycyny Lotniczej, Pfizer (United States), City of Hope

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

5737

Citations

View on Google Scholar

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

Abstract

Journal Details

Join JournalsHub

Welcome Back